News InhaleRx Limited

Equities

IRX

AU0000179475

Market Closed - Australian S.E. Other stock markets 12:46:06 2024-04-22 am EDT			5-day change	1st Jan Change
0.028 ^AUD	-9.68%		-9.68%	-3.45%

Mar. 28	InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	CI
Feb. 14	InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	Mar. 27	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 13	CI
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic	Jan. 10	MT
InhaleRx Secures Nearly AU$550,000 R&D tax Incentive Prepayment	Dec. 21	MT
InhaleRX Completes Phase One Trial for Pain Medication Device	Dec. 04	MT
InhaleRx Files Ethics Application for Panic Disorder Trial	23-10-17	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
InhaleRx Limited Announces Change of Registered Office Address	23-08-02	CI
InhaleRx Limited Announces Executive Changes	23-08-02	CI
InhaleRx Completes First Cohort of Phase One Clinical Trial	23-06-14	MT
Australian Shares Retreat Anew on Rate Hike, Slower-than-Expected GDP Growth	23-06-07	MT
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	23-06-07	MT
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	23-03-29	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22-12-22	MT
Inhalerx Limited Announces Fda Pre-Ind Application Update	22-12-11	CI
InhaleRx Limited Announces Board and Management Changes	22-09-26	CI
InhaleRx Limited Announces the Appointment of Darryl Davies as Chief Executive Officer	22-09-26	CI
InhaleRx Raises $810,000 From Share Placement	22-09-18	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News InhaleRx Limited

Equities

IRX

AU0000179475

Summary

Filters